Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Breast Tissues”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Testing effectiveness (Phase 2)Looking for participantsNCT06348134
What this trial is testing

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHER2-positive Breast CancerBreast Cancer
University of Chicago 74
Testing effectiveness (Phase 2)Study completedNCT00637026
What this trial is testing

Ph II Early BC Pre-Surgical Biologic Study

Who this might be right for
Breast Cancer
AstraZeneca 65
Testing effectiveness (Phase 2)Ended earlyNCT04441099
What this trial is testing

NBE-002 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerTriple Negative Breast Cancer
NBE-Therapeutics AG 12
Not applicableUnknownNCT06264934
What this trial is testing

An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner

Who this might be right for
Breast CancerBenign Breast Disease
Zedsen Limited 90
Testing effectiveness (Phase 2)UnknownNCT02934828
What this trial is testing

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Testing effectiveness (Phase 2)Study completedNCT04143711
What this trial is testing

Study of DF1001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 270
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Testing effectiveness (Phase 2)Study completedNCT00580333
What this trial is testing

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 51
Very early researchLooking for participantsNCT05921253
What this trial is testing

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

Who this might be right for
Breast CancerLymphoma
University of Oklahoma 104
Testing effectiveness (Phase 2)Ended earlyNCT06851442
What this trial is testing

Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8
Early research (Phase 1)Study completedNCT00882674
What this trial is testing

Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 8
Not applicableStudy completedNCT05067374
What this trial is testing

Hepatitis C Screening Paired With Mammography

Who this might be right for
Hepatitis CBreast Cancer
University Hospital, Montpellier 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT06018337
What this trial is testing

DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Who this might be right for
Metastatic Breast Cancer
DualityBio Inc. 541
Large-scale testing (Phase 3)Study completedNCT00091442
What this trial is testing

Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 751
Not applicableEnded earlyNCT02823262
What this trial is testing

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Who this might be right for
Breast CancerEstrogen Receptor Positive Breast CancerNode-negative Breast Cancer+1 more
Beth Israel Deaconess Medical Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT07796880
What this trial is testing

Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2 Low Breast CarcinomaEarly-Stage Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80
Early research (Phase 1)WithdrawnNCT06229392
What this trial is testing

Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Triple Negative
Rush University Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05607004
What this trial is testing

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Who this might be right for
Breast NeoplasmsInvasive Breast CancerEstrogen-receptor-positive Breast Cancer+1 more
Atossa Therapeutics, Inc. 87
Next Page